EUVIMEDEUVIMED entdecken
Klinische Studie (Phase III)Randomisierte kontrollierte Studie

Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper

Robert F Spiera iD, Sebastian Unizony, Kenneth J Warrington iD, Jennifer Sloane, Angeliki Giannelou, Michael C Nivens, Bolanle Akinlade, Wanling Wong, Rafia Bhore, Yong Lin, Frank Buttgereit, Valerie Devauchelle-Pensec und 6 weitere

New England Journal of Medicine · 05.10.2023 · 389 (14) · 1263-1272

DOI: 10.1056/nejmoa2303452 ↗

Kurz gefasst

Klinische Studie (Phase III) in der Zeitschrift New England Journal of Medicine, erschienen am 05.10.2023. Verfasst von Robert F Spiera und 17 weiteren Autor:innen. Beteiligte Einrichtung: From the Hospital for Special Surgery, Weill Cornell Medical College, New York (R.F.S.), and Regeneron Pharmaceuticals, Tarrytown (A.G., M.C.N., B.A.…. Hauptthemen laut MEDLINE: Polymyalgia Rheumatica, Antibodies, Monoclonal, Humanized, Drug Tapering. Die Arbeit wurde bisher 137-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Sanofi, Regeneron Pharmaceuticals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polymyalgia RheumaticaAntibodies, Monoclonal, HumanizedDrug TaperingHumansGlucocorticoidsPrednisoneRecurrenceTreatment OutcomeC-Reactive ProteinInterleukin-6 Inhibitors

Substanzen

GlucocorticoidsPrednisoneAntibodies, Monoclonal, HumanizedC-Reactive ProteinInterleukin-6 Inhibitorssarilumab

Autor:innen und Institutionen

  • From the Hospital for Special Surgery, Weill Cornell Medical College, New York (R.F.S.), and Regeneron Pharmaceuticals, Tarrytown (A.G., M.C.N., B.A., R.B., G.D.Y.) - both in New York; the Vasculitis and Glomerulonephri…

ORCID-Profile: Robert F Spiera, Kenneth J Warrington, Andrea Rubbert-Roth

Förderung

  • Sanofi
  • Regeneron Pharmaceuticals

Zitieren

APA

Spiera, R. F., Unizony, S., Warrington, K. J., Sloane, J., Giannelou, A., Nivens, M. C., Akinlade, B., Wong, W., Bhore, R., Lin, Y., Buttgereit, F., Devauchelle-Pensec, V., Rubbert-Roth, A., Yancopoulos, G. D., Marrache, F., Patel, N., Dasgupta, B., & SAPHYR Investigators (2023). Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper. New England Journal of Medicine, 389(14), 1263-1272. https://doi.org/10.1056/nejmoa2303452

Vancouver

Spiera RF, Unizony S, Warrington KJ, Sloane J, Giannelou A, Nivens MC, et al. Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper. New England Journal of Medicine. 2023;389(14):1263-1272. doi:10.1056/nejmoa2303452

BibTeX
@article{Spiera2023,
  author = {Spiera, Robert F and Unizony, Sebastian and Warrington, Kenneth J and Sloane, Jennifer and Giannelou, Angeliki and Nivens, Michael C and Akinlade, Bolanle and Wong, Wanling and Bhore, Rafia and Lin, Yong and Buttgereit, Frank and Devauchelle-Pensec, Valerie and Rubbert-Roth, Andrea and Yancopoulos, George D and Marrache, Frederic and Patel, Naimish and Dasgupta, Bhaskar and SAPHYR Investigators, SAPHYR Investigators},
  title = {Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper},
  journal = {New England Journal of Medicine},
  year = {2023},
  volume = {389},
  number = {14},
  pages = {1263--1272},
  doi = {10.1056/nejmoa2303452}
}
Kostenlos starten →